Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations
Eline W Muilwijk1,2, Bart G J Dekkers3, Stefanie S V Henriet2,4
1Department of Pharmacy, Radboud university medical center, Nijmegen, The Netherlands eline.muilwijk@radboudumc.nl roger.bruggemann@radboudumc.nl.
Abstract:
Combining voriconazole and flucloxacillin is indicated in patient cohorts experiencing both invasive aspergillosis and Gram-positive infections (e.g., patients with chronic granulomatous disease or postinfluenza pulmonary aspergillosis). We report a highly relevant interaction between voriconazole and flucloxacillin, resulting in subtherapeutic plasma voriconazole concentrations in more than 50% of patients, that poses a severe threat if not managed properly.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Related Concept Videos
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics: Drug–Drug Interactions
Antimicrobial Effectiveness
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Pharmacokinetics in Pediatric Patients: Drug Excretion
